Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway

Abstract All chronic renal disorders eventually lead to renal interstitial fibrosis (RIF). Chronic inflammation and pro-fibrotic substances are familiar companions of the fibrotic process. The Sulforaphane (Sul) molecule is particularly useful in protecting the liver from oxidative damage. To invest...

Full description

Bibliographic Details
Published in:	Applied Biological Chemistry
Main Authors:	Ziqing Yu, Wen He, Weiwu Shi
Format:	Article
Language:	English
Published:	SpringerOpen 2024-01-01
Subjects:	Anti-inflammatory Renal interstitial fibrosis Sulforaphane TGF-β/Smad
Online Access:	https://doi.org/10.1186/s13765-024-00858-x

Similar Items

The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment
by: Feilong Chen, et al.
Published: (2025-09-01)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01)

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2024-12-01)

Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)

SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis
by: Meng Tu, et al.
Published: (2024-10-01)

Identification of Tisp40 as an Essential Regulator of Renal Tubulointerstitial Fibrosis via TGF-β/Smads Pathway
by: Cheng-cheng Xiao, et al.
Published: (2017-06-01)

Differential regulation of TGF-β/Smad signaling in hepatic stallate cells between acute and chronic liver injuries
by: Katsunori eYoshida, et al.
Published: (2012-03-01)

Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation
by: Zhang Qingwei, et al.
Published: (2024-04-01)

The total polyphenolic glycoside extract of Lamiophlomis rotata ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway
by: Guoguo Wan, et al.
Published: (2023-02-01)

Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling
by: Qing Shi, et al.
Published: (2024-04-01)

CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism
by: Mian Liu, et al.
Published: (2025-07-01)

TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
by: Feng Xie, et al.
Published: (2014-10-01)

Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
by: Zhi-Hao Zhang, et al.
Published: (2018-09-01)

UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
by: Lijie Yang, et al.
Published: (2025-01-01)

GNMT inhibits intrauterine adhesion fibrosis through TGF-β1/Smad3 signaling pathway and its mechanism
by: GU Hong, et al.
Published: (2024-09-01)

Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition
by: Qun Yu, et al.
Published: (2022-05-01)

Mechanisms of the TGF-β1/Smad3-signaling pathway in gender differences in alcoholic liver fibrosis
by: Xiaomin Hong, et al.
Published: (2024-02-01)

Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
by: Hui Wang, et al.
Published: (2022-12-01)

INHBA knockdown inhibits renal fibrosis in mice following ischemia–reperfusion injury by suppressing activation of the TGF-β/Smad signaling pathway
by: Yifei Wang, et al.
Published: (2025-09-01)

Preclinical validation of TGFβ inhibitors as a novel therapeutic strategy for post-traumatic heterotopic ossification
by: Jaira Ferreira de Vasconcellos, et al.
Published: (2025-04-01)

SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
by: Qi Song, et al.
Published: (2024-12-01)

An intricate role of Ang II/AT1 in the modulation of monosodium glutamate-induced pulmonary fibrosis by TGF-β/Smad through quercetin
by: Arnab Banerjee, et al.
Published: (2025-07-01)

Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-β1/Smad signaling in schistosomiasis in mice
by: Ping Huang, et al.
Published: (2022-12-01)

Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice
by: Xianghe Chen, et al.
Published: (2024-02-01)

The Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer
by: Francesco Dituri, et al.
Published: (2019-09-01)

Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane <i>N</i>-acetylcysteine
by: Eun Suk Son, et al.
Published: (2021-06-01)

The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis
by: Pramod Mallikarjuna, et al.
Published: (2022-04-01)

Panaxatriol saponins exert anti-renal fibrosis by suppressing TNF-α mediated inflammation and TGF-β1/Smad3 signaling pathway
by: Si Yi, et al.
Published: (2025-12-01)

The promotive role of reticulocalbin 3 (RCN3) in the pathogenesis of keloid via TGFβ1/Smad2/Smad7 signaling pathway in vitro
by: Wang HongYu, et al.
Published: (2024-12-01)

The Role of the TGF-β Superfamily in Myocardial Infarction
by: Anis Hanna, et al.
Published: (2019-09-01)

Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway
by: Xudong Song, et al.
Published: (2022-07-01)

Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway
by: Chunjun Li, et al.
Published: (2023-02-01)

Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure
by: Feifei Zhang, et al.
Published: (2016-06-01)

Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial–Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway
by: Yifan Wang, et al.
Published: (2023-07-01)

TRPC3 contributes to cyclophosphamide-induced cystitis progression by enhancing bladder fibrosis through activation of the TGF-β/smad pathway
by: Ruixiang Luo, et al.
Published: (2025-04-01)

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
by: Xiongqun Peng, et al.
Published: (2023-09-01)

Advances on TGF-β/Smad signal pathway in hepatic fibrosis
by: Han Daoning, et al.
Published: (2021-09-01)

Traditional Chinese Medicine targeting the TGF-β/Smad signaling pathway as a potential therapeutic strategy for renal fibrosis
by: Hao Jiao, et al.
Published: (2025-05-01)

Environmentally relevant concentration PFNA promotes degradation of SMAD7 to drive progression of ovarian cancer via TGF-β/SMADs signaling pathway
by: Jiamin Zhong, et al.
Published: (2024-10-01)